Expression of transforming growth factor-β isoforms in human glomerular diseases

Kidney International

Volumn 49, Issue 2, 1996, Pages 461-469

  Yamamoto, Tatsuo ^b   Noble, Nancy A ^b   Cohen, Arthur H ^b   Nast, Cynthia C ^b   Hishida, Akira ^b   Gold, Leslie I ^b   Border, Wayne A ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ARTICLE; CHRONIC GLOMERULONEPHRITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; EXTRACELLULAR MATRIX; GENE EXPRESSION; GLOMERULUS; HUMAN; KIDNEY DISEASE; PRIORITY JOURNAL;

EID: 0030030447     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.65     Document Type: Article

References (46)

1. RISDON RA, SLOPER JC, DE WARDENER HE: Relationship between renal function and histologic changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet 2:363-366, 1968
2. NATH KA: Tubulointerstitial changes as a major determinant in the progression of renal disease. Am J Kidney Dis 20:1-17, 1992
3. D'AMICO G: Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy, and membranoproliferative glomerulonephritis: Survey of the recent literature. Am J Kidney Dis 20:315-323, 1992
4. OKUDA S, LANGUINO LR, RUOSLAHTI E, BORDER WA: Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. J Clin Invest 86:453-462, 1990
5. YAMAMOTO T, NAKAMURA T, NOBLE NA, RUOSLAHTI E, BORDER WA: Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90:1814-1818, 1993
6. BORDER WA, NOBLE NA: Transforming growth factor-β in tissue fibrosis. N Engl Med 331:1286-1292, 1994
7. BORDER WA, NOBLE NA: Fibrosis linked to TGF-β in yet another disease. J Clin Invest (in press)
8. DERYNCK R, LINDQUIST PB, LEE A, WEN D, TAMM T, GRAYCAR JL, RHEE L, MASON AJ, MILLER DA, COFFEY RJ, MOSES HL, CHEN EY: A new type of transforming growth factor β. EMBO J 7:3737-3743, 1988
9. GRAYCAR JL, MILLER DA, ARRICK BA, LYONS RM, MOSES HL, DERYNCK R: Human transforming growth factor β3: Recombinant expression, purification, and biological activities in comparison with transforming growth factor β1 and β2. Mol Endocrinol 3:1977-1986, 1989
10. ROBERTS AB, SPORN MB: Differential expression of the TGF-β isoforms in embryogenesis suggests specific roles in developing and adult tissues. Mol Reprod Dev 32:91-98, 1992
11. PELTON RW, SAXENA B, JONES M, MOSES HL, GOLD LI: Immunohisto-chemical localization of TGF-β1, TGF-β2, and TGF-β3 in the mouse embryo: Expression patterns suggest multiple roles during embryonic development. J Cell Biol 115:1091-1105, 1991
12. PELTON RW, DICKINSON ME, MOSES HL, HOGAN BLM: In situ hybridization analysis of TGF-β3 RNA expression during mouse development: Comparative studies with TGF-β1 and β2. Development (Camb) 110:609-620, 1990
13. JAKOWLEW SB, MEAD JE, DANIELPOUR D, WU J, ROBERTS AB, FAUSTO N: Transforming growth factor-beta (TGF-beta) isoforms in rat liver regeneration: Messenger RNA expression and activation of latent TGF-beta. Cell Regul 2:535-548, 1991
14. LEVINE JH, MOSES HL, GOLD LI, NANNEY LB: Spatial and temporal patterns of immunoreactive transforming growth factor beta 1, beta 2, and beta 3 during excisional wound repair. Am J Pathol 143:368-380, 1993
15. McMULLEN H, LONGAKER MT, CABRERA RC, SNG J, CANETE J, SIEBERT JW, LORENZ HP, GOLD LI: Analysis of TGF-β1, TGF-β2, and TGF-β3 immunoreactivity during ovine wound repair. Wound Repair Regen 3:141-156, 1995
16. BORDER WA, OKUDA S, LANGUINO LR, RUOSLAHTI E: Transforming growth factor-β regulates production of proteoglycans by mesangial cells. Kidney Int 37:689-695, 1990
17. NAKAMURA T, MILLER DE, RUOSLAHTI E, BORDER WA: Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-β. Kidney Int 41:1213-1221, 1992
18. KAGAMI S, BORDER WA, RUOSLAHTI E, NOBLE NA: Coordinated expression of β1 integrins and transforming growth factor-β-induced matrix proteins in glomerulonephritis. Lab Invest 69:68-76, 1993
19. TOMOOKA S, BORDER WA, MARSHALL BC, NOBLE NA: Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int 42:1462-1469, 1992
20. NAKAMURA T, FUKUI M, EBIHARA I, OSADA S, TOMINO Y, KOIDE H: Abnormal gene expression of matrix metalloproteinases and their inhibitor in glomeruli from diabetic rats. Renal Physiol Biochem 17:316-325, 1994
21. BORDER WA, OKUDA S, LANGUINO LR, SPORN MB, RUOSLAHTI E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 346:371-374, 1990
22. BORDER WA, NOBLE NA, YAMAMOTO T, HARPER JR, YAMAGUCHI Y, PIERSCHBACHER MD, RUOSLAHTI E: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 360:361-364, 1992
23. BALZA E, BORSI L, ALLEMANNI G, ZARDI L: Transforming growth factor β regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts. FEBS Lett 228:42-44, 1988
24. BARNES JL, HASTINGS RR, DE LA GARZA MA: Sequential expression of cellular fibronectin by platelets, macrophages, and mesangial cells in proliferative glomerulonephritis. Am J Pathol 145:585-597, 1994
25. JARNAGIN WR, ROCKEY DC, KOTELIANSKY VE, WANG S-S, BISSELL DM: Expression of variant fibronectins in wound healing: Cellular source and biological activity of the EIIA segment in rat hepatic fibrogenesis. J Cell Biol 127:2037-2048, 1994
26. LAIHO M, SAKESLA O, ANDREASEN PA, KESKI-OJA J: Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-β. J Cell Biol 103:2403-2410, 1986
27. LUND LR, RICCIO A, ANDREASEN AP, NIELSEN LS, KRISTENSEN P, LAIHO M, BLASI F, DANO K: Transforming growth factor-β is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts. EMBO J 6:1281-1286, 1987
28. EDWARDS DR, GILLIAN M, REYNOLDS JJ, WHITMAN SE, DOCHERTY AJP, ANGEL P, HEATH JK: Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6:1899-1904, 1987
29. OVERALL CM, WRANA JL, SODEK J: Independent regulation of collagenase, 74-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-β. J Biol Chem 264:1860-1869, 1989
30. CHURG J, BERNSTEIN J, GLASSOCK RJ: Renal Disease: Classification and Atlas of Glomerular Diseases (2nd ed). Tokyo, Igaku-Suoin, 1995
31. MILLER DA, LEE A, PELTON RW, CHEN EY, MOSES HL, DERYNCK R: Murine transforming growth factor-beta 2 cDNA sequence and expression in adult tissues and embryos. Mol Endocrinol 3: 1108-1114, 1989
32. MILLER DA, LEE A, MATSUI Y, CHEN EY, MOSES HL, DERYNCK R: Complementary DNA cloning of the murine transforming growth factor-beta 3 (TGF-beta 3) precursor and the comparative expression of TGF beta 3 and TGF beta 1 messenger RNA in murine embryos and adult tissues. Mol Endocrinol 3:1926-1934, 1989
33. YOSHIOKA K, TAKEMURA T, MURAKAMI K, OKADA M, HINO S, MIYAMOTO H, MAKI S: Transforming growth factor-β protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest 68:154-163, 1993
34. TERRELL TG, WORKING PK, CHOW CP, GREEN JD: Pathology of recombinant human transforming growth factor-β1 in rats and rabbits. Int Rev Exp Pathol 34:43-67, 1993
35. ZUGMAIER G, PAIK S, WILDING G, KNABBE G, BANO M, LUPU R, DESCHAUER B, SIMPSON S, DICKSON RB, LIPPMAN M: Transforming growth factor β1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice. Cancer Res 51:3590-3594, 1991
36. ISAKA Y, FUJIWARA Y, UEDA N, KANEDA Y, KAMADA T, IMAI E: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J Clin Invest 92:2597-2601, 1993
37. SANDERSON N, FACTOR V, NAGY P, KOPP J, KONDAIAH P, WAKEFIELD L, ROBERTS AB, SPORN MB, THORGEIRSSON SS: Hepatic expression of mature TGF-β1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 92:2572-2576, 1995
38. SHIHAB FS, YAMAMOTO T, NAST CC, COHEN AH, NOBLE NA, GOLD LI, BORDER WA: Transforming growth factor-β and matrix protein expression in acute and chronic rejection of human renal allografts. J Am Soc Nephrol (in press)
39. SANTANA A, SAXENA B, NOBLE NA, GOLD LI, MARSHALL BC: Increased expression of transforming growth factor β isoforms (β1, β2, β3) in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol (in press)
40. MILANI S, HERBST H, SCHUPPAN D, STEIN H, SURRENTI C: Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. Am J Pathol 139:1221-1229, 1991
41. PELTONEN J, KÄHÄRI L, JAAKKOLA S, KÄHÄRI V-M, VARGA J, UITTO J, JIMENEZ SA: Evaluation of transforming growth factor β and type I procollagen gene expression in fibrotic skin diseases by in situ hybridization. J Invest Dermatol 94:365-371, 1990
42. GRUSCHWITZ M, MÜLLER PU, SEPP N, HOFER E, FONTANA A, WICK G: Transcription and expression of transforming growth factor type beta in the skin of progressive systemic sclerosis: A mediator of fibrosis? J Invest Dermatol 94:197-203, 1990
43. KULOZIK M, HOGG A, LANKAT-BUTTGEREIT B, KRIEG T: Co-localization of transforming growth factor β2 with α1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J Clin Invest 86:917-922, 1990
44. O'REILLY MA, DANIELPOUR D, ROBERTS AB, SPORN M: Regulation of expression of transforming growth factor-β2 by transforming growth factor-β isoforms is dependent upon cell type. Growth Factors 6:193-201, 1992
45. KIM SJ, ANGEL P, LAGYATIS R, HATTORI K, KIM KY, SPORN MB, KARIN M, ROBERTS AB: Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex. Mol Cell Biol 10:1492-1497, 1990
46. PETEN EP, STRIKER LJ, CAROME MA, ELLIOT SJ, YANG, C-W, STRIKER GE: The contribution of increased collagen synthesis to human glomerulosclerosis: A quantitative analysis of a2IV collagen mRNA expression by comptetitive polymerase chain reaction. J Exp Med 176:1571-1576, 1992